Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1009207 New York, NY
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,398,891
-$7,980,136 QoQ
Shares Held
774,055
-55.0% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 311 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. AMRX ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 1,267,706 $101,074,198
2 ALKS
Alkermes plc.
 1,312,031 $68,750,423
3 XERS
Xeris Biopharma Holdings, Inc.
 7,804,758 $61,813,683
4 PCRX
Pacira BioSciences, Inc.
 1,950,332 $49,479,922
5 ZTS
Zoetis Inc.
 537,515 $38,625,827
6 KNSA
Kiniksa Pharmaceuticals International, plc
 569,756 $36,435,896
7 SUPN
Supernus Pharmaceuticals, Inc.
 767,668 $35,704,237
8 TAK
Takeda Pharmaceutical Co Ltd
 2,049,467 $32,852,956

All Filings in AMRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,398,891 774,055
2026-03-31 $21,379,027 1,719,954
2025-12-31 $33,539,360 2,661,854
2025-09-30 $15,667,761 1,565,211
2025-06-30 $7,472,279 923,644
2025-03-31 $132,705 15,836
2024-06-30 $570,833 89,895
2024-03-31 $1,370,796 226,204
2023-12-31 $4,042,838 666,036
2023-09-30 $3,692,145 874,916
2023-06-30 $1,928,900 622,226
2023-03-31 $875,850 630,109
2022-12-31 $1,370,785 688,837
2022-09-30 $526,917 260,850
2022-06-30 $600,787 188,927
2022-03-31 $1,059,175 253,999
2021-12-31 $756,925 158,022
2021-09-30 $96,344 18,042
2021-03-31 $826,269 122,774